McKellar Q A
Department of Veterinary Pharmacology, University of Glasgow Veterinary School, Bearsden, UK.
Vet Parasitol. 1994 Aug;54(1-3):249-58. doi: 10.1016/0304-4017(94)90093-0.
The milbemycins are the only novel broad spectrum anthelmintic chemicals to reach the market place in the last 10 years. Many new systems for delivery and strategies for rational use have, however, been introduced. Boluses which are retained by virtue of specific gravity and by variable geometry are now available. They contain benzimidazoles, morantel, ivermectin and levamisole. Their release mechanisms involve preferential corrosion of a retaining metal core, constant diffusion from a laminated ethylene acetate sandwich, and a hydrostatic pump driven by osmotic pressure. Some are biodegradable. Experimental delivery systems have been developed incorporating ear implants and liposomes. The anthelmintic efficacy of some drugs has been potentiated by the synergistic action of metabolic inhibitors and these combinations hold promise for the future. Much new information is now available on those factors which affect anthelmintic efficacy such as concurrent administration with food and the presence of the target parasites themselves. This knowledge provides a sound basis for the rational use of anthelmintic drugs.
米尔倍霉素是过去10年中唯一进入市场的新型广谱抗蠕虫化学药物。然而,已经引入了许多新的给药系统和合理使用策略。现在有借助比重和可变几何形状来留存的大丸剂。它们含有苯并咪唑、莫仑太尔、伊维菌素和左旋咪唑。其释放机制包括保留金属芯的优先腐蚀、从层压乙酸乙烯酯夹层的持续扩散以及由渗透压驱动的静水压泵。有些是可生物降解的。已经开发了结合耳植入物和脂质体的实验性给药系统。一些药物的抗蠕虫功效通过代谢抑制剂的协同作用得到了增强,这些组合在未来有很大前景。现在有很多关于影响抗蠕虫功效的因素的新信息,比如与食物同时给药以及目标寄生虫本身的存在。这些知识为合理使用抗蠕虫药物提供了坚实的基础。